Bioequivalence Study of Etodolac Extended Release Tablets USP 600mg Under Fed Condition
Status:
Completed
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
This is a open Label, balanced, randomized, single dose, two-treatment, two-sequence,
two-period, crossover, oral pivotal bioequivalence study. The purpose of this study is to
assess the bioequivalence between Test Product and the corresponding Reference Product under
fed condition in healthy, adult human subjects.